ArticleFrontiers in nutrition2026
Ginsenoside Rb1 alleviates overtraining-induced oxidative stress in mouse liver by stimulating mitophagy via Nrf2 pathway.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Moderate exercise induces beneficial adaptive responses in the body, whereas sustained high-intensity exercise without adequate recovery leads to overtraining syndrome (OTS), a pathological condition associated with multiple organ damage, especially liver injury. Currently, safe and effective nutritional interventions for OTS-induced liver injury remain limited. This study aimed to investigate the protective effect of ginsenoside Rb1 (Gs-Rb1), the primary bioactive component of ginseng, against OTS-induced liver injury and to elucidate its underlying molecular mechanism. Methods: We established an overtraining (OT) mouse model using ICR mice, and evaluated the hepatoprotective effect of Gs-Rb1 using histopathological observation, biochemical analysis, immunofluorescence staining, Western blot, and other related techniques. The core regulatory mechanism was verified using chloroquine (CQ, an autophagy inhibitor) and ML385 (a specific Nrf2 inhibitor). Results: OT intervention induced significant oxidative stress and liver injury in mouse liver, whereas Gs-Rb1 administration effectively alleviated liver damage, improved exercise performance, and mitigated OT-induced oxidative stress and mitochondrial impairment in the liver by activating mitophagy. Mechanistically, Gs-Rb1 promoted the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2), and further activated the downstream PTEN-induced kinase 1 (PINK1)/Parkin RBR E3 ubiquitin protein ligase (Parkin) pathway to drive mitophagy. Inhibitor validation experiments further confirmed that the hepatoprotective effect of Gs-Rb1 was autophagy-dependent, and Nrf2 was a key regulator of Gs-Rb1-mediated mitophagy. Discussion: This study demonstrates that Gs-Rb1 ameliorates OT-induced oxidative stress in mouse liver via Nrf2-dependent mitophagy. Our findings indicate that targeting mitophagy via the Nrf2 pathway represents a promising nutritional strategy to alleviate overtraining-related liver injury, providing a theoretical basis for the application of natural bioactive compounds such as Gs-Rb1 in the field of sports nutrition and health promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.